Find out more about the Chemistry in Cells PhD and how to apply at our online OPEN DAY on Friday 12th November, 3-5pm (GMT). To register your place, please email [email protected]. #MedChem #phdposition #BlackinChem #ChemBio #EDI #diversitymatters

Great to get into the lab and do some chemistry!

A privilege to be a part of this amazing team in Pharmacology Oxford for the last six months. It has been great to play a role in building this lab!

Did you miss this? A new study led by Professor Tim Walsh at the Department of Biology and Ineos Oxford Institute for Antimicrobial Research shows that antimicrobial resistant bacteria are present in newborn babies a few hours after birth bit.ly/3QqHKh0

Finally an ‘official’ DPhil student in the Lanyon-Hogg group (Pharmacology Oxford) and Walsh group (Ineos Oxford Institute for Antimicrobial Research) on the Chemistry in Cells course!

TLH group Christmas dinner ft. analogues of Tom Lanyon-Hogg ☃️🎁🥂

🚨Internship opportunity🚨 Interested in science, evidence, policy, and how they interact? CSaP are recruiting PhD interns for the 2024–25 academic year Applications for our first intake (Sept–Dec 2024) are now open Apply by 29 April 👉 shorturl.at/ptxJ8 #internship

Pre-existing Aspergillus/ABPA is associated with increased rates of hospitalisation and sepsis during COVID-19 in people with Cystic Fibrosis. A great collaboration with MRC Centre for Medical Mycology and @ECFSRegistry now published in Journal of CF. Read more: tinyurl.com/uudappec @Adilia76645023

Great to kick off my time at CSaP with exploring the potential of engineering biology with interdisciplinary experts from across Cambridge.

“Science isn't useful if it stays in science in terms of having a direct impact on people's lives. Scientific papers are not changing the price of bread.”

In the first study of its kind, scientists at the IOI and Department of Pharmacology at University of Oxford have developed a new molecule that can suppress the evolution of resistance in bacteria by blocking their 'SOS response' 🦠 Find out more ➡️ ow.ly/VARv50RSp08

The first paper from our lab is out now in Chemical Science: "Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance" Chemical Science #MyFirstChemSci pubs.rsc.org/en/content/art…

The University of Oxford has published a summary of the Tom Lanyon-Hogg group's new paper! Read the article below, and read the full text published in Chemical Science for free: doi.org/10.1039/D4SC00…

📽️ IOI DPhil student Jacob Bradbury tells us about his recent research developing a molecule that can block the 'SOS response' in bacteria. Watch the video and find out more ⤵️ ow.ly/6eSI50Sff64 Pharmacology Oxford

"If a chimpanzee had a brain that was twice its size it would be sat here having this conversation with us!"

The end of the cASPerCF: "The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience." doi.org/10.1186/s13063… @Adilia76645023 MRC Centre for Medical Mycology conect4children

The RSC BMCS Postgraduate Symposium was a brilliant meeting and it was a pleasure to get the chance to talk about our SOS response inhibitors work!

New paper from our lab in RSC Chemical Biology describing how to optimise a new assay for drug screening against a complicated enzyme target in only 2 weeks - see below thread from first-author Adam Winnifrith pubs.rsc.org/en/Content/Art…